79 related articles for article (PubMed ID: 26375249)
1. RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes.
Khan FH; Pandian V; Ramraj SK; Aravindan S; Natarajan M; Azadi S; Herman TS; Aravindan N
Oncotarget; 2015 Nov; 6(34):36522-34. PubMed ID: 26375249
[TBL] [Abstract][Full Text] [Related]
2. De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution.
Somasundaram DB; Subramanian K; Aravindan S; Yu Z; Natarajan M; Herman T; Aravindan N
Sci Rep; 2019 Aug; 9(1):11766. PubMed ID: 31409909
[TBL] [Abstract][Full Text] [Related]
3. Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes.
Khan FH; Pandian V; Ramraj S; Natarajan M; Aravindan S; Herman TS; Aravindan N
BMC Cancer; 2015 Jul; 15():514. PubMed ID: 26159519
[TBL] [Abstract][Full Text] [Related]
4. Retinal Degeneration Protein 3 (RD3) in normal human tissues: Novel insights.
Aravindan S; Somasundaram DB; Kam KL; Subramanian K; Yu Z; Herman TS; Fung KM; Aravindan N
Sci Rep; 2017 Oct; 7(1):13154. PubMed ID: 29030614
[TBL] [Abstract][Full Text] [Related]
5. CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours.
Vega FM; Colmenero-Repiso A; Gómez-Muñoz MA; Rodríguez-Prieto I; Aguilar-Morante D; Ramírez G; Márquez C; Cabello R; Pardal R
EBioMedicine; 2019 Nov; 49():82-95. PubMed ID: 31685444
[TBL] [Abstract][Full Text] [Related]
6. TRPM7 maintains progenitor-like features of neuroblastoma cells: implications for metastasis formation.
Middelbeek J; Visser D; Henneman L; Kamermans A; Kuipers AJ; Hoogerbrugge PM; Jalink K; van Leeuwen FN
Oncotarget; 2015 Apr; 6(11):8760-76. PubMed ID: 25797249
[TBL] [Abstract][Full Text] [Related]
7. A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma.
Shohet JM; Ghosh R; Coarfa C; Ludwig A; Benham AL; Chen Z; Patterson DM; Barbieri E; Mestdagh P; Sikorski DN; Milosavljevic A; Kim ES; Gunaratne PH
Cancer Res; 2011 Jun; 71(11):3841-51. PubMed ID: 21498633
[TBL] [Abstract][Full Text] [Related]
8. Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease.
Ramraj SK; Aravindan S; Somasundaram DB; Herman TS; Natarajan M; Aravindan N
Oncotarget; 2016 Apr; 7(14):18605-19. PubMed ID: 26921195
[TBL] [Abstract][Full Text] [Related]
9. Bin1 is linked to metastatic potential and chemosensitivity in neuroblastoma.
Zhong X; Hoelz DJ; Kumar HR; Sandoval JA; Rescorla FJ; Hickey RJ; Malkas LH
Pediatr Blood Cancer; 2009 Sep; 53(3):332-7. PubMed ID: 19418541
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a neuroblastoma mouse model by subcutaneous xenograft transplantation and its use to study metastatic neuroblastoma.
Gao Q; Chen CF; Dong Q; Hou L; Chen X; Zhi YL; Li X; Lu HT; Zhang HY
Genet Mol Res; 2015 Dec; 14(4):16297-307. PubMed ID: 26662423
[TBL] [Abstract][Full Text] [Related]
11. CD57(high) neuroblastoma cells have aggressive attributes ex situ and an undifferentiated phenotype in patients.
Schlitter AM; Dorneburg C; Barth TF; Wahl J; Schulte JH; Brüderlein S; Debatin KM; Beltinger C
PLoS One; 2012; 7(8):e42025. PubMed ID: 22900004
[TBL] [Abstract][Full Text] [Related]
12. A Metastatic Mouse Model Identifies Genes That Regulate Neuroblastoma Metastasis.
Seong BK; Fathers KE; Hallett R; Yung CK; Stein LD; Mouaaz S; Kee L; Hawkins CE; Irwin MS; Kaplan DR
Cancer Res; 2017 Feb; 77(3):696-706. PubMed ID: 27899382
[TBL] [Abstract][Full Text] [Related]
13. The metastatic microenvironment: lung-derived factors control the viability of neuroblastoma lung metastasis.
Maman S; Edry-Botzer L; Sagi-Assif O; Meshel T; Yuan W; Lu W; Witz IP
Int J Cancer; 2013 Nov; 133(10):2296-306. PubMed ID: 23649556
[TBL] [Abstract][Full Text] [Related]
14. β-Carotene inhibits neuroblastoma cell invasion and metastasis in vitro and in vivo by decreasing level of hypoxia-inducible factor-1α.
Kim YS; Lee HA; Lim JY; Kim Y; Jung CH; Yoo SH; Kim Y
J Nutr Biochem; 2014 Jun; 25(6):655-64. PubMed ID: 24746828
[TBL] [Abstract][Full Text] [Related]
15. miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14.
Xiang X; Mei H; Zhao X; Pu J; Li D; Qu H; Jiao W; Zhao J; Huang K; Zheng L; Tong Q
Oncotarget; 2015 Sep; 6(26):22452-66. PubMed ID: 26084291
[TBL] [Abstract][Full Text] [Related]
16. Loss of caspase-8 expression does not correlate with MYCN amplification, aggressive disease, or prognosis in neuroblastoma.
Fulda S; Poremba C; Berwanger B; Häcker S; Eilers M; Christiansen H; Hero B; Debatin KM
Cancer Res; 2006 Oct; 66(20):10016-23. PubMed ID: 17047064
[TBL] [Abstract][Full Text] [Related]
17. The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation.
Pandey GK; Mitra S; Subhash S; Hertwig F; Kanduri M; Mishra K; Fransson S; Ganeshram A; Mondal T; Bandaru S; Ostensson M; Akyürek LM; Abrahamsson J; Pfeifer S; Larsson E; Shi L; Peng Z; Fischer M; Martinsson T; Hedborg F; Kogner P; Kanduri C
Cancer Cell; 2014 Nov; 26(5):722-37. PubMed ID: 25517750
[TBL] [Abstract][Full Text] [Related]
18. Integrin α4 Enhances Metastasis and May Be Associated with Poor Prognosis in MYCN-low Neuroblastoma.
Young SA; McCabe KE; Bartakova A; Delaney J; Pizzo DP; Newbury RO; Varner JA; Schlaepfer DD; Stupack DG
PLoS One; 2015; 10(5):e0120815. PubMed ID: 25973900
[TBL] [Abstract][Full Text] [Related]
19. RNAi-mediated stathmin suppression reduces lung metastasis in an orthotopic neuroblastoma mouse model.
Byrne FL; Yang L; Phillips PA; Hansford LM; Fletcher JI; Ormandy CJ; McCarroll JA; Kavallaris M
Oncogene; 2014 Feb; 33(7):882-90. PubMed ID: 23396365
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma.
Ren Y; Chan HM; Fan J; Xie Y; Chen YX; Li W; Jiang GP; Liu Q; Meinhardt A; Tam PK
Oncogene; 2006 Jun; 25(25):3501-8. PubMed ID: 16449971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
